SGXP Sgx Pharmaceuticals (MM)

 

 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM S-8

REGISTRATION STATEMENT UNDER THE
SECURITIES ACT OF 1933

SGX Pharmaceuticals, Inc.

(Exact name of registrant as specified in its charter)

Delaware		06-1523147
(State or other jurisdiction of incorporation or		(I.R.S. Employer Identification No.)
organization)
10505 Roselle Street		92121
San Diego, California		(Zip Code)
(Address of Principal Executive Offices)

2005 Equity Incentive Plan
2005 Employee Stock Purchase Plan
2005 Non-Employee Directors’ Stock Option Plan
(Full title of the plans)

Michael Grey
President and CEO
SGX Pharmaceuticals, Inc.
10505 Roselle Street
San Diego, CA 92121
(Name and address of agent for services)

(858) 558-4850
(Telephone number, including area code, of agent for service)

Copies to:

Annette North, Esq.		Frederick T. Muto, Esq.
General Counsel and		J. Patrick Loofbourrow, Esq.
Corporate Secretary		Cooley Godward Kronish LLP
SGX Pharmaceuticals, Inc.		4401 Eastgate Mall
10505 Roselle Street		San Diego, CA 92121
San Diego, CA 92121		(858) 550-6000
(858) 558-4850

     Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer o		Accelerated filer o		Non-accelerated filer o		Smaller reporting company þ
				(Do not check if a smaller reporting company)

CALCULATION OF REGISTRATION FEE

Proposed

Maximum

Proposed Maximum

Title of Each Class of Securities to

Amount to be

Offering

Aggregate

Amount of

be Registered

Registered (1)

Price per Share (2)

Offering Price (2)

Registration Fee

Common Stock issuable under the 2005 Equity Incentive Plan (par value $0.001 per share)

500,000 shares(3)

$1.355

$677,500

$26.63

Common Stock issuable under the 2005 Employee Stock Purchase Plan (par value $0.001 per share)

150,000 shares(4)

$1.355

$203,250

$ 7.98

Common Stock issuable under the 2005 Non-Employee Directors’ Stock Option Plan (par value $0.001) per share

62,500 (5)

$1.355

$ 84,688

$ 3.33

Total

712,500 shares

N/A

$965,438

$37.94

 

 

INCORPORATION BY REFERENCE OF CONTENTS OF
REGISTRATION STATEMENTS ON FORM S-8 NO. 333-131428

     This Registration Statement is being filed for the purpose of increasing the number of securities of the same class as other securities for which a Registration Statement on Form S-8 of the Registrant relating to the same benefit plans is effective. The Registrant previously registered shares of its Common Stock for issuance under the 2005 EIP, the 2005 ESPP and the Directors’ Plan under a Registration Statement on Form S-8 filed with the Securities and Exchange Commission on February 1, 2006 (File No. 333-131428). Pursuant to General Instruction E to Form S-8, this Registration Statement hereby incorporates by reference the contents of the Registration Statement referenced above (File No. 333-131428).

TABLE OF CONTENTS

EXHIBITS

Exhibit
Number		Description
4.1 (1)		Form of Registrant’s Amended and Restated Certificate of Incorporation.
4.2 (2)		Form of Registrant’s Amended and Restated Bylaws.
4.3 (3)		Form of Common Stock Certificate of the Registrant.
5.1		Opinion of Cooley Godward Kronish LLP.
23.1		Consent of Independent Registered Public Accounting Firm.
23.2		Consent of Cooley Godward Kronish LLP. Reference is made to Exhibit 5.1.
24.1		Power of Attorney. Reference is made to the signature page of this Form S-8.
99.1 (3)		2005 Equity Incentive Plan and Form of Stock Option Agreement and Form of Stock Option Grant Notice thereunder.
99.2 (4)		Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement for Executive Officers under the Registrant’s 2005 Equity Incentive Plan.
99.3 (3)		2005 Employee Stock Purchase Plan and Form of Offering Document thereunder.
99.4 (5)		2005 Non-Employee Directors’ Stock Option Plan and Form of Stock Option Agreement and Form of Stock Option Grant Notice thereunder.

SIGNATURES

     Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Diego, State of California, on May 27, 2008.

POWER OF ATTORNEY

      KNOW ALL PERSONS BY THESE PRESENTS , that each person whose signature appears below constitutes and appoints TODD MYERS and MICHAEL GREY, and each of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or either of them, or their or his substitutes or substitute, may lawfully do or cause to be done by virtue hereof.

     Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.

Signature		Title		Date
/s/ Michael Grey   Michael Grey		President, Chief Executive Officer and Member of the Board of Directors (Principal Executive Officer)		May 27, 2008
/s/ Todd Myers   Todd Myers, C.P.A.		Chief Financial Officer (Principal Financial and Accounting Officer)		May 27, 2008
/s/ Christopher S. Henney   Christopher S. Henney, Ph.D., D.Sc.		Chairman of the Board of Directors		May 27, 2008
/s/ Louis C. Bock   Louis C. Bock		Member of the Board of Directors		May 27, 2008
/s/ Karin Eastham   Karin Eastham, C.P.A.		Member of the Board of Directors		May 27, 2008
Jean-Francois Formela, M.D.		Member of the Board of Directors		May 27, 2008
/s/ Joseph Turner   Joseph Turner		Member of the Board of Directors		May 27, 2008

EXHIBIT INDEX

Exhibit
Number		Description
4.1 (1)		Form of Registrant’s Amended and Restated Certificate of Incorporation.
4.2 (2)		Form of Registrant’s Amended and Restated Bylaws.
4.3 (3)		Form of Common Stock Certificate of the Registrant.
5.1		Opinion of Cooley Godward Kronish LLP.
23.1		Consent of Independent Registered Public Accounting Firm.
23.2		Consent of Cooley Godward Kronish LLP. Reference is made to Exhibit 5.1.
24.1		Power of Attorney. Reference is made to the signature page of this Form S-8.
99.1 (3)		2005 Equity Incentive Plan and Form of Stock Option Agreement and Form of Stock Option Grant Notice thereunder.
99.2 (4)		Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement for Executive Officers under the Registrant’s 2005 Equity Incentive Plan.
99.3 (3)		2005 Employee Stock Purchase Plan and Form of Offering Document thereunder.
99.4 (5)		2005 Non-Employee Directors’ Stock Option Plan and Form of Stock Option Agreement and Form of Stock Option Grant Notice thereunder.

Sgx Pharmaceuticals (MM) (NASDAQ:SGXP)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024

Sgx Pharmaceuticals (MM) (NASDAQ:SGXP)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024